Search hospitals > New Jersey > Princeton
Princeton Medical Institute
Claim this profilePrinceton, New Jersey 08540
Global Leader in Alzheimer's Disease
Conducts research for Major Depressive Disorder
Conducts research for Depression
Conducts research for Attention Deficit Hyperactivity Disorder (ADHD)
Conducts research for Cognitive Impairment
65 reported clinical trials
2 medical researchers
Summary
Princeton Medical Institute is a medical facility located in Princeton, New Jersey. This center is recognized for care of Alzheimer's Disease, Major Depressive Disorder, Depression, Attention Deficit Hyperactivity Disorder (ADHD), Cognitive Impairment and other specialties. Princeton Medical Institute is involved with conducting 65 clinical trials across 34 conditions. There are 2 research doctors associated with this hospital, such as James Wolberg, MD and Jeffrey Apter, MD.Top PIs
James Wolberg, MDGlobal Medical Institutes, LLC2 years of reported clinical research
Studies Major Depressive Disorder
Studies Depression
4 reported clinical trials
5 drugs studied
Jeffrey Apter, MDGlobal Medical Institutes, LLC2 years of reported clinical research
Studies Alzheimer's Disease
1 reported clinical trial
2 drugs studied
Clinical Trials running at Princeton Medical Institute
Depression
Alzheimer's Disease
Major Depressive Disorder
Cognitive Impairment
Smoking Cessation
Vaping Cessation
Bipolar Depression
Alzheimer's Dementia
Alzheimer's
Mild Cognitive Impairment
Investigational Drug
for Bipolar Depression
This trial is testing a new medication called SEP-4199 CR to see if it can help adults aged 18-65 who have depression from Bipolar I disorder. The study will compare the effects of the medication to see if it reduces symptoms of depression. SEP-4199 has shown antidepressant efficacy in a previous study for bipolar depression.
Recruiting1 award Phase 35 criteria
Psilocybin
for Depression
Approximately 240 eligible adult participants (≥18 years old) who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) criteria for Major Depressive Disorder (MDD) will be enrolled. Participants will be randomly assigned to receive a single oral dose of Psilocybin 25 mg, Psilocybin 5 mg, or inactive placebo. The purpose of this study is to evaluate the efficacy, safety, and tolerability of Psilocybin 25 mg versus placebo in adults with MDD, as assessed by the difference between groups in change in depressive symptoms from Baseline to Day 43 post-dose, and to characterize the durability of initial treatment effect and subsequent response to optional Psilocybin 25 mg re-administration(s) during the 1-year Follow-up Period.
Recruiting1 award Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Princeton Medical Institute?
Princeton Medical Institute is a medical facility located in Princeton, New Jersey. This center is recognized for care of Alzheimer's Disease, Major Depressive Disorder, Depression, Attention Deficit Hyperactivity Disorder (ADHD), Cognitive Impairment and other specialties. Princeton Medical Institute is involved with conducting 65 clinical trials across 34 conditions. There are 2 research doctors associated with this hospital, such as James Wolberg, MD and Jeffrey Apter, MD.